Adaptive Biotechnologies (ADPT) Minority Interest (2021 - 2026)

Adaptive Biotechnologies has disclosed Minority Interest across 6 years of filings, most recently posting $7.9 million for Q1 2026.

• Minority Interest for Q1 2026 came in at $7.9 million, up 4011.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.9 million (up 4011.39% YoY), and the FY2025 annual result was $6.2 million, up 2871.43% from the prior year.
• Minority Interest came in at $7.9 million for Q1 2026 at Adaptive Biotechnologies, up from $6.2 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $7.9 million in Q1 2026 to a low of -$224000.0 in Q4 2024.
• The 5-year median for Minority Interest is -$95000.0 (2023), against an average of $730411.8.
• Across the five-year window, Minority Interest slumped 675.0% in 2023 and jumped 4011.39% in 2026, its largest moves.
• Adaptive Biotechnologies' Minority Interest stood at -$67000.0 in 2022, then plunged by 80.6% to -$121000.0 in 2023, then slumped by 85.12% to -$224000.0 in 2024, then soared by 2871.43% to $6.2 million in 2025, then advanced by 27.27% to $7.9 million in 2026.
• The last three Minority Interest figures came in at $7.9 million (Q1 2026), $6.2 million (Q4 2025), and -$182000.0 (Q3 2025), per Business Quant data.